Back to today’s briefing

Story perspectives

SAP Surges Past Novo Nordisk as Europe's Top Company

3/24/2025

48 5

Summary

Story summary

SAP has overtaken Novo Nordisk as Europe's most valuable public company, with a market cap of €312 billion.
SAP's shares surged over 40% in the past year, fueled by rising demand for cloud and AI solutions.
Novo Nordisk's market value fell nearly 50% following disappointing results for its weight-loss drug, CagriSema.
Investor confidence in SAP's growth strategy has strengthened amid Novo Nordisk's heightened competition in pharmaceuticals.

1 of 1

Story summary

SAP has overtaken Novo Nordisk as Europe's most valuable public company, with a market cap of €312 billion.
SAP's shares surged over 40% in the past year, fueled by rising demand for cloud and AI solutions.
Novo Nordisk's market value fell nearly 50% following disappointing results for its weight-loss drug, CagriSema.
Investor confidence in SAP's growth strategy has strengthened amid Novo Nordisk's heightened competition in pharmaceuticals.